Title : Sensitized activation of Fos and brain-derived neurotrophic factor in the medial prefrontal cortex and ventral tegmental area accompanies behavioral sensitization to amphetamine.

Pub. Date : 2011 Sep

PMID : 21570990






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sensitized activation of Fos and brain-derived neurotrophic factor in the medial prefrontal cortex and ventral tegmental area accompanies behavioral sensitization to amphetamine. Amphetamine Fos proto-oncogene, AP-1 transcription factor subunit Rattus norvegicus
2 Amphetamine challenge increased Fos and BDNF expression in the mPFC regardless of prior drug experience, and further augmented mPFC BDNF expression in sensitized rats. Amphetamine Fos proto-oncogene, AP-1 transcription factor subunit Rattus norvegicus
3 Similarly, more Fos-FG and Fos-BDNF double-labeling was observed in the mPFC of sensitized rats compared to drug-naive rats after amphetamine challenge. Amphetamine Fos proto-oncogene, AP-1 transcription factor subunit Rattus norvegicus
4 Similarly, more Fos-FG and Fos-BDNF double-labeling was observed in the mPFC of sensitized rats compared to drug-naive rats after amphetamine challenge. Amphetamine Fos proto-oncogene, AP-1 transcription factor subunit Rattus norvegicus
5 Repeated amphetamine treatment also increased VTA BDNF, while both acute and repeated amphetamine treatment increased Fos and Fos-BDNF co-labeling, an effect enhanced in sensitized rats. Amphetamine Fos proto-oncogene, AP-1 transcription factor subunit Rattus norvegicus
6 Repeated amphetamine treatment also increased VTA BDNF, while both acute and repeated amphetamine treatment increased Fos and Fos-BDNF co-labeling, an effect enhanced in sensitized rats. Amphetamine Fos proto-oncogene, AP-1 transcription factor subunit Rattus norvegicus